Delivery Order SPE2DB20D1100-SPE2DB25FC1G8
- Not listed
- The Defense Logistics Agency awarded a $8,630.28 delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev 100 mg capsules (60-count units) on July 15, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $8,630.28. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to support federal medical procurement requirements. The order is scheduled for ultimate completion by October 16, 2025, and will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $8,630.28 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $8,630.28 delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Ofev 100 mg capsules (60-count units), with performance completion targeted for April 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order functions as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.29 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ofev 150 mg capsules (60-count units) under a firm fixed-price contract valued at $8,590.58, with completion targeted for August 20, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $51,662.58 on August 13, 2025, for the supply of Ofev 100 mg capsules (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16 under a firm fixed-price delivery order contract. The order is set to be completed by October 21, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $25,771.74 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract is scheduled for completion by October 8, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order representing a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC1G8Delivery Order
The Defense Logistics Agency awarded a $25,851.16 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of Ofev 100 mg capsules in a quantity of 60 units. This is a non-set-aside contract with a completion deadline of May 27, 2025, and performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The company's contract portfolio demonstrates consistent capability to fulfill federal medical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 5/5/25 |